Seagen (Canada)

Seagen (Canada)

Seagen Inc. is an American biotechnology company focused on developing and commercializing innovative, empowered monoclonal antibody-based therapies for the treatment of cancer. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Seagen (Canada), Canada, covering academic research published from 2002 to 2023. Read More.


Open Access Percentage

94%


Total
Publications

142


Total Open
Publications

133


Total
Citations

15K


Open Access
Percentage

94%


Total
Publications

142


Total Open
Publications

133


Total
Citations

15K

Wikipedia

Website

download

Breakdown

26% 37% 31% 6%

Publisher Open

26%

Both

37%

Other Platform Open

31%

Closed

6%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

024681012141618Total Publications
2002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Open

Closed

Publisher Open

5%OA Journal

OA Journal 5%

4

Hybrid 28%

25

No Guarantees 67%

60

Other Platform Open

Domain 95%

91

Institution 40%

38

Other Internet 4%

4

Preprint 3%

3

Public 1%

1

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
90
Europe PMC
Domain
58
University of California - eScholarship University of California
Institution
9
University of North Carolina at Chapel Hill - Carolina Digital Repository
Institution
7
University College London - UCL Discovery
Institution
6
Research Square
Preprint
3
KU Leuven - Lirias
Institution
3
University of Southern Denmark - University of Southern Denmark Research Portal
Institution
2
University of Milano-Bicocca - BOA - Bicocca Open Archive
Institution
2
University of Michigan - Deep Blue
Institution
2
1 / 4

Data updated 13 August 2024

Share

Share

Share